TrialCancer2025
Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer.
Wataru Fukuokaya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it